ZHENG, LIANGHONG,ZHU, JIE,ZHAO, LING,AI, MICHAEL,LI, OULAN,ZHANG, KANG
申请号：
CA2998158
公开号：
CA2998158A1
申请日:
2016.09.09
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
Disclosed herein are methods and pharmaceutical compositions for the treatment of glaucoma by interfering with expression of genes, such as p16, in cells of the eye. These methods and compositions employ nucleic acid based therapies.
